市場調査レポート

商品コード

1308630

生体吸収性ポリマー市場の2030年までの予測：製品タイプ別、用途別、地域別の世界分析

Bioresorbable Polymers Market Forecasts to 2030 - Global Analysis By Product Type, Application, and By Geography

出版日: 2023年07月01日 | 発行: Stratistics Market Research Consulting

| ページ情報: 英文 175+ Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,150 650,554円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 822,990円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 995,426円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,175,700円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、世界の生体吸収性ポリマー市場は2023年に15億2,000万米ドルを占め、予測期間中のCAGRは15.7％で成長し、2030年には42億3,000万米ドルに達すると予測されています。

生体吸収性ポリマーは、体内に安全に吸収される可能性があるため、医療業界で頻繁に利用されている物質です。これらのポリマーが身体に植え付けられた場合、剥離する必要はないです。さらに、医療産業における生体吸収性ポリマーの利用は、ポリ乳酸（PLA）、ポリグリコリド（PGA）、PLA/PGAのコポリマーなどの生体吸収性ポリマーを分解します。吸収性スクリューやアンカーへの非構造的ドラッグデリバリーのために、これらの材料は機械的性能や吸収速度に合わせてカスタマイズすることができ、これが市場の成長を促進します。

市場力学：

促進要因

有利な償還

生体吸収性ポリマー市場の拡大を後押ししている主な要因の1つは、多くの外科手術に対する有利な償還状況です。例えば、米国CMSは、米国市民を対象とした外科医による術前、術中、術後を含むすべての外科治療に対する支払いをカバーすることを目的とした世界の手術パッケージを提供しています。その結果、生体吸収性ポリマーの市場開発は、保険適用率の向上がもたらす外科手術件数の増加により、今後数年間で発展すると予想されます。

抑制要因

熟練者の不足

この分野の開発により、生体吸収性材料をベースとした医療用品の技術的展望と用途は急速に発展しています。このため、医師やその他の医療専門家は、生体吸収性材料で作られた医薬品を管理するのに必要なスキルを持つことが求められています。その結果、洗練された生体吸収性医療用品は、外科医や医療サービスの医師が創傷閉鎖に使用することはないです。

機会：

ドラッグデリバリー用途での生体吸収性ポリマーの需要の増加

周期的投与、一定量の治療薬の時間制御放出、親水性薬と疎水性薬の異なる放出などを可能にすることで、ポリマーはドラッグデリバリー技術を大幅に改善しました。通常の材料を使用していた初期から、この分野は大きく発展してきました。ドラッグデリバリーにおける現代の画期的な進歩は、現在では、ユニークな生物学的活性を発揮することを目的とし、特定の荷物に合わせたポリマーの合理的な設計の上に築かれています。生体吸収性ポリマーは、リガンドで表面を変化させる能力を持ち、人体内でプライバシーを守り、標的を絞った薬物投与を可能にします。また、目的の場所への調節された放出、不均衡な分子（タンパク質など）に対する安定性、不均衡な分子に対する安定性を可能にします。

脅威

従来のプラスチックと比較した場合の高コスト

生体吸収性ポリマーの市場は、分解性ポリマーやその他のポリマーに比べてコストが高いことが大きな制約となっています。市場はより速いペースで開発されると予想されるもの、従来のポリマーの市場に比べればまだ小さいです。その結果、従来のポリマーの製造は規模の経済の恩恵を受けているが、生体吸収性ポリマーの製造は小規模です。その結果、製造コストが大きくなり、完成品の需要が高まる。しかし、生体吸収性ポリマーは1回限りの治療で済み、全体的なサービスが向上します。長期的には、このようなポリマーのコスト高による影響を軽減することができます。

COVID-19影響：

疫病の流行は文明のほとんどあらゆる面に影響を及ぼしています。生体吸収性ポリマーの市場は、世界のサプライチェーンの中断と計画工程の遅延の結果、低迷が見られました。医療業界の需要減退がこの問題の根源だっています。原材料が不足し、商品が目的地に届くまでに時間がかかったのです。しかし、医療や製薬の分野で生体吸収性ポリマーの需要が高まると、その市場は回復し始めました。医療セクターは流行中も機能し続け、世界市場を支えました。2021年に広範なワクチン接種キャンペーンが開始された後、さらに発展途上諸国が生体吸収性ポリマーの製造を拡大しました。

予測期間中、ポリ乳酸セグメントが最大になると予想される：

ポリ乳酸セグメントは、その優れた加工能力と機械的強度により、有利な成長を遂げると推定され、PLAは最も商業的に実行可能なバイオポリマーの一つです。PLAは毒性がなく、生分解性、リサイクル性、堆肥化可能で、生物によって代謝されます。熱加工性の向上や、さまざまな成形加工が可能であることなど、多くの点で従来のポリマーよりも優れています。PLAの主なサブタイプはPLLAとPDLLAの2つです。

予測期間中にCAGRが最も高くなると予想されるのは整形外科用デバイスセグメントである：

整形外科用器デバイスセグメントは、予測期間中にCAGRが最も高くなると予測されています。この用途の高成長は、整形外科疾患の有病率の増加、一人当たり所得の上昇による生活水準の向上、医療支出の増加、より質の高い医療に対する需要の高まり、世界各国における生体吸収性ステントに対する認知度の向上など、多くの要因によるものです。

最大のシェアを占める地域：

アジア太平洋地域は、新興国市場の急速な経済拡大と一人当たり可処分所得の増加により、予測期間中に最大の市場シェアを占めると予測されます。インド、中国、日本などの高成長国の存在、人口の急速な高齢化、病院数の増加、支援的な償還政策、有益な政府イニシアチブの実施、一人当たり所得の増加、医療部門への多額の投資、最先端の手術製品に対する需要、地方への私立病院の進出などが、アジア太平洋地域の市場を牽引する追加要因となっています。

CAGRが最も高い地域：

北米は、整形外科や薬物送達用途での製品使用の増加により、予測期間中に最も高いCAGRを示すと予測されています。北米の生体吸収性ポリマー市場は、医療分野の研究開発の重要な中心地である米国によってさらに活性化されています。さらに、整形外科やドラッグデリバリー用途でのポリマーニーズの拡大と医療支出の増加が、この地域での製品需要を押し上げると予想されています。

主な発展：

2023年6月、Evonikはシンガポールに新工場を建設し、アルコキシド事業を世界に拡大します。今後、アルコキシド触媒は、PETプラスチックのケミカルリサイクルにおける使用を通じて、循環型経済においても大きな役割を果たすでしょう。

レポート内容

地域および国レベルセグメントの市場セグメンテーション
新規参入企業への戦略的提言
2021年、2022年、2023年、2026年、2030年の市場データを網羅
市場動向
市場推定に基づく主要ビジネスセグメントにおける戦略的提言
主要な共通トレンドをマッピングした競合情勢
詳細な戦略、財務、最近の動向を含む企業プロファイル
最新の技術動向をマッピングしたサプライチェーン動向

無料のカスタマイズサービス：

本レポートをご購読のお客様には、以下のいずれかの無料カスタマイズオプションをご提供いたします：

企業プロファイル
- 追加市場プレイヤーの包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他欧州
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他アジア太平洋地域
南米
- アルゼンチン
- ブラジル
- チリ
- その他南米
中東・アフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他中東・アフリカ

第8章主な発展

契約、パートナーシップ、提携、合弁事業
買収と合併
新製品の上市
事業拡大
その他の主要戦略

第9章企業プロファイル

Evonik Industries AG
Foster Corporation
Ashland Global Holdings Inc.
REVA Medical, LLC
Bezwada Biomedical, LLC
BMG Incorporated
Foryou Medical Devices Co., Ltd
Musashino Chemical Laboratory, Ltd.
Henan Xinghan Biotechnology Co. Ltd.
KLS Martin Group
DSM Biomedical
Corbion N.V.
Zeus Industrial Products
Abbott
3D Biotek LLC
Sunstar Suisse S.A.
Futerro

図表

List of Tables

Table 1 Global Bioresorbable Polymers Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Bioresorbable Polymers Market Outlook, By Product Type (2021-2030) ($MN)
Table 3 Global Bioresorbable Polymers Market Outlook, By Polysaccharides (2021-2030) ($MN)
Table 4 Global Bioresorbable Polymers Market Outlook, By Polylactic acid (2021-2030) ($MN)
Table 5 Global Bioresorbable Polymers Market Outlook, By Poly-d,l-lactic acid (PDLLA) (2021-2030) ($MN)
Table 6 Global Bioresorbable Polymers Market Outlook, By Poly (l-lactic) acid (PLLA) (2021-2030) ($MN)
Table 7 Global Bioresorbable Polymers Market Outlook, By Polyglycolic acid (2021-2030) ($MN)
Table 8 Global Bioresorbable Polymers Market Outlook, By Polycaprolactone (2021-2030) ($MN)
Table 9 Global Bioresorbable Polymers Market Outlook, By Poly(lactic-co-glycolic acid) (PLGA) (2021-2030) ($MN)
Table 10 Global Bioresorbable Polymers Market Outlook, By Agro-Polymers (2021-2030) ($MN)
Table 11 Global Bioresorbable Polymers Market Outlook, By Bio-Polyesters (2021-2030) ($MN)
Table 12 Global Bioresorbable Polymers Market Outlook, By Other Product Types (2021-2030) ($MN)
Table 13 Global Bioresorbable Polymers Market Outlook, By Application (2021-2030) ($MN)
Table 14 Global Bioresorbable Polymers Market Outlook, By Orthopedic devices (2021-2030) ($MN)
Table 15 Global Bioresorbable Polymers Market Outlook, By Hip (2021-2030) ($MN)
Table 16 Global Bioresorbable Polymers Market Outlook, By Knee (2021-2030) ($MN)
Table 17 Global Bioresorbable Polymers Market Outlook, By Trauma (2021-2030) ($MN)
Table 18 Global Bioresorbable Polymers Market Outlook, By Spine (2021-2030) ($MN)
Table 19 Global Bioresorbable Polymers Market Outlook, By Drug delivery (2021-2030) ($MN)
Table 20 Global Bioresorbable Polymers Market Outlook, By Parenteral (2021-2030) ($MN)
Table 21 Global Bioresorbable Polymers Market Outlook, By Oral (2021-2030) ($MN)
Table 22 Global Bioresorbable Polymers Market Outlook, By Other Drug deliveries (2021-2030) ($MN)
Table 23 Global Bioresorbable Polymers Market Outlook, By Other Applications (2021-2030) ($MN)
Table 24 North America Bioresorbable Polymers Market Outlook, By Country (2021-2030) ($MN)
Table 25 North America Bioresorbable Polymers Market Outlook, By Product Type (2021-2030) ($MN)
Table 26 North America Bioresorbable Polymers Market Outlook, By Polysaccharides (2021-2030) ($MN)
Table 27 North America Bioresorbable Polymers Market Outlook, By Polylactic acid (2021-2030) ($MN)
Table 28 North America Bioresorbable Polymers Market Outlook, By Poly-d,l-lactic acid (PDLLA) (2021-2030) ($MN)
Table 29 North America Bioresorbable Polymers Market Outlook, By Poly (l-lactic) acid (PLLA) (2021-2030) ($MN)
Table 30 North America Bioresorbable Polymers Market Outlook, By Polyglycolic acid (2021-2030) ($MN)
Table 31 North America Bioresorbable Polymers Market Outlook, By Polycaprolactone (2021-2030) ($MN)
Table 32 North America Bioresorbable Polymers Market Outlook, By Poly(lactic-co-glycolic acid) (PLGA) (2021-2030) ($MN)
Table 33 North America Bioresorbable Polymers Market Outlook, By Agro-Polymers (2021-2030) ($MN)
Table 34 North America Bioresorbable Polymers Market Outlook, By Bio-Polyesters (2021-2030) ($MN)
Table 35 North America Bioresorbable Polymers Market Outlook, By Other Product Types (2021-2030) ($MN)
Table 36 North America Bioresorbable Polymers Market Outlook, By Application (2021-2030) ($MN)
Table 37 North America Bioresorbable Polymers Market Outlook, By Orthopedic devices (2021-2030) ($MN)
Table 38 North America Bioresorbable Polymers Market Outlook, By Hip (2021-2030) ($MN)
Table 39 North America Bioresorbable Polymers Market Outlook, By Knee (2021-2030) ($MN)
Table 40 North America Bioresorbable Polymers Market Outlook, By Trauma (2021-2030) ($MN)
Table 41 North America Bioresorbable Polymers Market Outlook, By Spine (2021-2030) ($MN)
Table 42 North America Bioresorbable Polymers Market Outlook, By Drug delivery (2021-2030) ($MN)
Table 43 North America Bioresorbable Polymers Market Outlook, By Parenteral (2021-2030) ($MN)
Table 44 North America Bioresorbable Polymers Market Outlook, By Oral (2021-2030) ($MN)
Table 45 North America Bioresorbable Polymers Market Outlook, By Other Drug deliveries (2021-2030) ($MN)
Table 46 North America Bioresorbable Polymers Market Outlook, By Other Applications (2021-2030) ($MN)
Table 47 Europe Bioresorbable Polymers Market Outlook, By Country (2021-2030) ($MN)
Table 48 Europe Bioresorbable Polymers Market Outlook, By Product Type (2021-2030) ($MN)
Table 49 Europe Bioresorbable Polymers Market Outlook, By Polysaccharides (2021-2030) ($MN)
Table 50 Europe Bioresorbable Polymers Market Outlook, By Polylactic acid (2021-2030) ($MN)
Table 51 Europe Bioresorbable Polymers Market Outlook, By Poly-d,l-lactic acid (PDLLA) (2021-2030) ($MN)
Table 52 Europe Bioresorbable Polymers Market Outlook, By Poly (l-lactic) acid (PLLA) (2021-2030) ($MN)
Table 53 Europe Bioresorbable Polymers Market Outlook, By Polyglycolic acid (2021-2030) ($MN)
Table 54 Europe Bioresorbable Polymers Market Outlook, By Polycaprolactone (2021-2030) ($MN)
Table 55 Europe Bioresorbable Polymers Market Outlook, By Poly(lactic-co-glycolic acid) (PLGA) (2021-2030) ($MN)
Table 56 Europe Bioresorbable Polymers Market Outlook, By Agro-Polymers (2021-2030) ($MN)
Table 57 Europe Bioresorbable Polymers Market Outlook, By Bio-Polyesters (2021-2030) ($MN)
Table 58 Europe Bioresorbable Polymers Market Outlook, By Other Product Types (2021-2030) ($MN)
Table 59 Europe Bioresorbable Polymers Market Outlook, By Application (2021-2030) ($MN)
Table 60 Europe Bioresorbable Polymers Market Outlook, By Orthopedic devices (2021-2030) ($MN)
Table 61 Europe Bioresorbable Polymers Market Outlook, By Hip (2021-2030) ($MN)
Table 62 Europe Bioresorbable Polymers Market Outlook, By Knee (2021-2030) ($MN)
Table 63 Europe Bioresorbable Polymers Market Outlook, By Trauma (2021-2030) ($MN)
Table 64 Europe Bioresorbable Polymers Market Outlook, By Spine (2021-2030) ($MN)
Table 65 Europe Bioresorbable Polymers Market Outlook, By Drug delivery (2021-2030) ($MN)
Table 66 Europe Bioresorbable Polymers Market Outlook, By Parenteral (2021-2030) ($MN)
Table 67 Europe Bioresorbable Polymers Market Outlook, By Oral (2021-2030) ($MN)
Table 68 Europe Bioresorbable Polymers Market Outlook, By Other Drug deliveries (2021-2030) ($MN)
Table 69 Europe Bioresorbable Polymers Market Outlook, By Other Applications (2021-2030) ($MN)
Table 70 Asia Pacific Bioresorbable Polymers Market Outlook, By Country (2021-2030) ($MN)
Table 71 Asia Pacific Bioresorbable Polymers Market Outlook, By Product Type (2021-2030) ($MN)
Table 72 Asia Pacific Bioresorbable Polymers Market Outlook, By Polysaccharides (2021-2030) ($MN)
Table 73 Asia Pacific Bioresorbable Polymers Market Outlook, By Polylactic acid (2021-2030) ($MN)
Table 74 Asia Pacific Bioresorbable Polymers Market Outlook, By Poly-d,l-lactic acid (PDLLA) (2021-2030) ($MN)
Table 75 Asia Pacific Bioresorbable Polymers Market Outlook, By Poly (l-lactic) acid (PLLA) (2021-2030) ($MN)
Table 76 Asia Pacific Bioresorbable Polymers Market Outlook, By Polyglycolic acid (2021-2030) ($MN)
Table 77 Asia Pacific Bioresorbable Polymers Market Outlook, By Polycaprolactone (2021-2030) ($MN)
Table 78 Asia Pacific Bioresorbable Polymers Market Outlook, By Poly(lactic-co-glycolic acid) (PLGA) (2021-2030) ($MN)
Table 79 Asia Pacific Bioresorbable Polymers Market Outlook, By Agro-Polymers (2021-2030) ($MN)
Table 80 Asia Pacific Bioresorbable Polymers Market Outlook, By Bio-Polyesters (2021-2030) ($MN)
Table 81 Asia Pacific Bioresorbable Polymers Market Outlook, By Other Product Types (2021-2030) ($MN)
Table 82 Asia Pacific Bioresorbable Polymers Market Outlook, By Application (2021-2030) ($MN)
Table 83 Asia Pacific Bioresorbable Polymers Market Outlook, By Orthopedic devices (2021-2030) ($MN)
Table 84 Asia Pacific Bioresorbable Polymers Market Outlook, By Hip (2021-2030) ($MN)
Table 85 Asia Pacific Bioresorbable Polymers Market Outlook, By Knee (2021-2030) ($MN)
Table 86 Asia Pacific Bioresorbable Polymers Market Outlook, By Trauma (2021-2030) ($MN)
Table 87 Asia Pacific Bioresorbable Polymers Market Outlook, By Spine (2021-2030) ($MN)
Table 88 Asia Pacific Bioresorbable Polymers Market Outlook, By Drug delivery (2021-2030) ($MN)
Table 89 Asia Pacific Bioresorbable Polymers Market Outlook, By Parenteral (2021-2030) ($MN)
Table 90 Asia Pacific Bioresorbable Polymers Market Outlook, By Oral (2021-2030) ($MN)
Table 91 Asia Pacific Bioresorbable Polymers Market Outlook, By Other Drug deliveries (2021-2030) ($MN)
Table 92 Asia Pacific Bioresorbable Polymers Market Outlook, By Other Applications (2021-2030) ($MN)
Table 93 South America Bioresorbable Polymers Market Outlook, By Country (2021-2030) ($MN)
Table 94 South America Bioresorbable Polymers Market Outlook, By Product Type (2021-2030) ($MN)
Table 95 South America Bioresorbable Polymers Market Outlook, By Polysaccharides (2021-2030) ($MN)
Table 96 South America Bioresorbable Polymers Market Outlook, By Polylactic acid (2021-2030) ($MN)
Table 97 South America Bioresorbable Polymers Market Outlook, By Poly-d,l-lactic acid (PDLLA) (2021-2030) ($MN)
Table 98 South America Bioresorbable Polymers Market Outlook, By Poly (l-lactic) acid (PLLA) (2021-2030) ($MN)
Table 99 South America Bioresorbable Polymers Market Outlook, By Polyglycolic acid (2021-2030) ($MN)
Table 100 South America Bioresorbable Polymers Market Outlook, By Polycaprolactone (2021-2030) ($MN)
Table 101 South America Bioresorbable Polymers Market Outlook, By Poly(lactic-co-glycolic acid) (PLGA) (2021-2030) ($MN)
Table 102 South America Bioresorbable Polymers Market Outlook, By Agro-Polymers (2021-2030) ($MN)
Table 103 South America Bioresorbable Polymers Market Outlook, By Bio-Polyesters (2021-2030) ($MN)
Table 104 South America Bioresorbable Polymers Market Outlook, By Other Product Types (2021-2030) ($MN)
Table 105 South America Bioresorbable Polymers Market Outlook, By Application (2021-2030) ($MN)
Table 106 South America Bioresorbable Polymers Market Outlook, By Orthopedic devices (2021-2030) ($MN)
Table 107 South America Bioresorbable Polymers Market Outlook, By Hip (2021-2030) ($MN)
Table 108 South America Bioresorbable Polymers Market Outlook, By Knee (2021-2030) ($MN)
Table 109 South America Bioresorbable Polymers Market Outlook, By Trauma (2021-2030) ($MN)
Table 110 South America Bioresorbable Polymers Market Outlook, By Spine (2021-2030) ($MN)
Table 111 South America Bioresorbable Polymers Market Outlook, By Drug delivery (2021-2030) ($MN)
Table 112 South America Bioresorbable Polymers Market Outlook, By Parenteral (2021-2030) ($MN)
Table 113 South America Bioresorbable Polymers Market Outlook, By Oral (2021-2030) ($MN)
Table 114 South America Bioresorbable Polymers Market Outlook, By Other Drug deliveries (2021-2030) ($MN)
Table 115 South America Bioresorbable Polymers Market Outlook, By Other Applications (2021-2030) ($MN)
Table 116 Middle East & Africa Bioresorbable Polymers Market Outlook, By Country (2021-2030) ($MN)
Table 117 Middle East & Africa Bioresorbable Polymers Market Outlook, By Product Type (2021-2030) ($MN)
Table 118 Middle East & Africa Bioresorbable Polymers Market Outlook, By Polysaccharides (2021-2030) ($MN)
Table 119 Middle East & Africa Bioresorbable Polymers Market Outlook, By Polylactic acid (2021-2030) ($MN)
Table 120 Middle East & Africa Bioresorbable Polymers Market Outlook, By Poly-d,l-lactic acid (PDLLA) (2021-2030) ($MN)
Table 121 Middle East & Africa Bioresorbable Polymers Market Outlook, By Poly (l-lactic) acid (PLLA) (2021-2030) ($MN)
Table 122 Middle East & Africa Bioresorbable Polymers Market Outlook, By Polyglycolic acid (2021-2030) ($MN)
Table 123 Middle East & Africa Bioresorbable Polymers Market Outlook, By Polycaprolactone (2021-2030) ($MN)
Table 124 Middle East & Africa Bioresorbable Polymers Market Outlook, By Poly(lactic-co-glycolic acid) (PLGA) (2021-2030) ($MN)
Table 125 Middle East & Africa Bioresorbable Polymers Market Outlook, By Agro-Polymers (2021-2030) ($MN)
Table 126 Middle East & Africa Bioresorbable Polymers Market Outlook, By Bio-Polyesters (2021-2030) ($MN)
Table 127 Middle East & Africa Bioresorbable Polymers Market Outlook, By Other Product Types (2021-2030) ($MN)
Table 128 Middle East & Africa Bioresorbable Polymers Market Outlook, By Application (2021-2030) ($MN)
Table 129 Middle East & Africa Bioresorbable Polymers Market Outlook, By Orthopedic devices (2021-2030) ($MN)
Table 130 Middle East & Africa Bioresorbable Polymers Market Outlook, By Hip (2021-2030) ($MN)
Table 131 Middle East & Africa Bioresorbable Polymers Market Outlook, By Knee (2021-2030) ($MN)
Table 132 Middle East & Africa Bioresorbable Polymers Market Outlook, By Trauma (2021-2030) ($MN)
Table 133 Middle East & Africa Bioresorbable Polymers Market Outlook, By Spine (2021-2030) ($MN)
Table 134 Middle East & Africa Bioresorbable Polymers Market Outlook, By Drug delivery (2021-2030) ($MN)
Table 135 Middle East & Africa Bioresorbable Polymers Market Outlook, By Parenteral (2021-2030) ($MN)
Table 136 Middle East & Africa Bioresorbable Polymers Market Outlook, By Oral (2021-2030) ($MN)
Table 137 Middle East & Africa Bioresorbable Polymers Market Outlook, By Other Drug deliveries (2021-2030) ($MN)
Table 138 Middle East & Africa Bioresorbable Polymers Market Outlook, By Other Applications (2021-2030) ($MN)
Table 139 Middle East & Africa Snowmobile Market Outlook, By Other Product Types (2021-2030) ($MN)
Table 140 Middle East & Africa Snowmobile Market Outlook, By Engine Type (2021-2030) ($MN)
Table 141 Middle East & Africa Snowmobile Market Outlook, By Two-Stroke Engine (2021-2030) ($MN)
Table 142 Middle East & Africa Snowmobile Market Outlook, By Four-Stroke Engine (2021-2030) ($MN)
Table 143 Middle East & Africa Snowmobile Market Outlook, By Engine Capacity (2021-2030) ($MN)
Table 144 Middle East & Africa Snowmobile Market Outlook, By <500 CC (2021-2030) ($MN)
Table 145 Middle East & Africa Snowmobile Market Outlook, By 500 CC to 800 CC (2021-2030) ($MN)
Table 146 Middle East & Africa Snowmobile Market Outlook, By 800 CC & above (2021-2030) ($MN)
Table 147 Middle East & Africa Snowmobile Market Outlook, By Seating (2021-2030) ($MN)
Table 148 Middle East & Africa Snowmobile Market Outlook, By Single Seater (2021-2030) ($MN)
Table 149 Middle East & Africa Snowmobile Market Outlook, By Two Seater (2021-2030) ($MN)
Table 150 Middle East & Africa Snowmobile Market Outlook, By Three Seater (2021-2030) ($MN)
Table 151 Middle East & Africa Snowmobile Market Outlook, By Sales Channel (2021-2030) ($MN)
Table 152 Middle East & Africa Snowmobile Market Outlook, By Franchised Stores (2021-2030) ($MN)
Table 153 Middle East & Africa Snowmobile Market Outlook, By Sports Stores (2021-2030) ($MN)
Table 154 Middle East & Africa Snowmobile Market Outlook, By Speciality Stores (2021-2030) ($MN)
Table 155 Middle East & Africa Snowmobile Market Outlook, By Online (2021-2030) ($MN)
Table 156 Middle East & Africa Snowmobile Market Outlook, By Other Sales Channels (2021-2030) ($MN)

Product Code: SMRC23330

According to Stratistics MRC, the Global Bioresorbable Polymers Market is accounted for $1.52 billion in 2023 and is expected to reach $4.23 billion by 2030 growing at a CAGR of 15.7% during the forecast period. Bioresorbable polymers are substance that is frequently utilised in the healthcare industry because it may be safely absorbed by the body. When these polymers are planted on the body, they do not need to be dethatched. Moreover, the utilization of the Bioresorbable polymers in the healthcare industry breaks down bioresorbable polymers such polylactide (PLA), polyglycolide (PGA), and copolymers of PLA/PGA. For the non-structural drug delivery to resorbable screws and anchors, these materials may be customised to match mechanical performance and resorption rates which drive the growth of the market.

Market Dynamics:

Driver:

Favourable reimbursement

One of the main factors propelling the expansion of the bioresorbable polymers market is the favourable reimbursement status for a number of surgical procedures. For instance, the US CMS offers the worldwide surgical package, which aims to cover payments for all surgical treatments which includes preoperative, intraoperative, and postoperative carried out by surgeons for US citizens. As a result, the market for bioresorbable polymers is anticipated to develop over the next few years as a result of the rising number of surgical operations brought on by better insurance coverage.

Restraint:

Lack of skilled personnels

Due to developments in this area, the technical landscape and applications for medical goods based on bioresorbable materials are developing quickly. This urges doctors and other healthcare professionals to have the skills necessary to manage medicinal goods made of bioresorbable materials. As a result, sophisticated bioresorbable medical items are not used for wound closure by medical surgeons or doctors from healthcare services.

Opportunity:

Increasing demand for bioresorbable polymers for drug delivery applications

By permitting cyclic dosing, controlled release of therapeutic agents in constant amounts throughout time, and different releases of both hydrophilic and hydrophobic medications, polymers have considerably improved drug delivery technology. Since its early days of using ordinary materials, the field has substantially grown. Modern breakthroughs in drug delivery are now built on the rational design of polymers intended to exert unique biological activities and tailored for a particular cargo. Bioresorbable polymers have the capacity to change surfaces with ligands for privacy and targeted drug administration in the human body. They also allow regulated release to the desired place, stability to unbalanced molecules (such as proteins), and stability to imbalanced molecules.

Threat:

High cost when compared to traditional plastics

The market for bioresorbable polymers is severely constrained by the higher cost of bioresorbable polymers compared to degradable and other polymers. Although the market anticipates a faster pace of development, it is still smaller than the market for traditional polymers. As a result, the manufacturing of traditional polymers benefits from economies of scale, whereas the production of bioresorbable polymers is small-scale. As a result, the cost of production is greater, boosting demand for the finished product. Bioresorbable polymers, however, provide a one-time fix and improved services overall. Long-term, this can lessen the impact of these polymers' greater cost.

COVID-19 Impact:

The epidemic has had an impact on almost every facet of civilization. The market for bioresorbable polymers has seen a downturn as a result of the interruptions in the global supply chain and the delays in planned processes. The medical industry's declining demand was the root of this problem. Raw resources were scarce, and it took longer for goods to get where they were going. But when the demand for bioresorbable polymers was raised in the medical and pharmaceutical sectors, the market for them began to rebound. The medical sector continued to function during the epidemic, supporting the world market. Following the start of the widespread vaccination campaign in 2021, additional developing countries expanded the manufacture of bioresorbable polymers.

The polylactic acid segment is expected to be the largest during the forecast period:

The polylactic acid segment is estimated to have a lucrative growth, due to its excellent process ability and mechanical strength, PLA is one of the most commercially viable biopolymers. PLA is non-toxic, biodegradable, recyclable, compostable, and is metabolised by living things. It is superior to conventional polymers in a number of ways, including improved thermal processability and the ability to be processed through a variety of moulding processes. The two primary subtypes of PLA are PLLA and PDLLA.

The orthopedic devices segment is expected to have the highest CAGR during the forecast period:

The orthopedic devices segment is anticipated to witness the highest CAGR growth during the forecast period, due to the major use of resorbable polymers is in orthopaedics. The high growth in this application is attributed to a number of factors, including an increase in the prevalence of orthopaedic disorders, an improvement in standard of living brought on by rising per capita income, rising healthcare spending, a rise in the demand for higher quality medical care, and increased awareness of bioresorbable stents in numerous nations around the world.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the rapid economic expansion of developing nations and rising per capita disposable income. The presence of high-growth economies like India, China, and Japan, as well as the quick ageing of the population, the rising number of hospitals, supportive reimbursement policies, the implementation of helpful government initiatives, rising per capita income, significant investments in the healthcare sector, demand for cutting-edge surgery products, and the expansion of private hospitals into rural areas are additional factors driving the market in APAC.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to rising product use in orthopaedics and medication delivery applications. The bioresorbable polymers market in North America is further fueled by the U.S., which serves as a significant centre for research and development in the healthcare sector. Additionally, it is anticipated that the expanding need for polymers in orthopaedics and drug delivery applications, together with rising healthcare spending, would drive up demand for the product in the area the expanding need for polymers in orthopaedics and drug delivery applications, as well as more healthcare spending, are all expected to drive up product demand in this region.

Key players in the market

Some of the key players profiled in the Bioresorbable Polymers Market include Evonik Industries AG, Foster Corporation, Ashland Global Holdings Inc., REVA Medical, LLC, Bezwada Biomedical, LLC, BMG Incorporated, Foryou Medical Devices Co., Ltd, Musashino Chemical Laboratory, Ltd., Henan Xinghan Biotechnology Co. Ltd., KLS Martin Group, DSM Biomedical, Corbion N.V., Zeus Industrial Products, Abbott, 3D Biotek LLC, Sunstar Suisse S.A. and Futerro

Key Developments:

In June 2023, Evonik launches new TEGO® Rad 2550 slip and defoamer additive for radiation-curing inks and coatings, The new TEGO® Rad 2550 is a clear, low viscosity liquid that effectively reduces static and dynamic surface tension in both conventional UV- and LED-cured formulations.

In June 2023, Evonik expands global alkoxides business with new Singapore plant. In future, alkoxide catalysts will also play a bigger role in the circular economy through their use in the chemical recycling of PET plastics.

Product Types Covered:

Polysaccharides
Polylactic acid
Polyglycolic acid
Polycaprolactone
Poly(lactic-co-glycolic acid) (PLGA)
Agro-Polymers
Bio-Polyesters
Other Product Types

Applications Covered:

Orthopedic devices
Drug delivery
Other Applications

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Bioresorbable Polymers Market, By Product Type

5.1 Introduction
5.2 Polysaccharides
5.3 Polylactic acid
- 5.3.1 Poly-d,l-lactic acid (PDLLA)
- 5.3.2 Poly (l-lactic) acid (PLLA)
5.4 Polyglycolic acid
5.5 Polycaprolactone
5.6 Poly(lactic-co-glycolic acid) (PLGA)
5.7 Agro-Polymers
5.8 Bio-Polyesters
5.9 Other Product Types

6 Global Bioresorbable Polymers Market, By Application

6.1 Introduction
6.2 Orthopedic devices
- 6.2.1 Hip
- 6.2.2 Knee
- 6.2.3 Trauma
- 6.2.4 Spine
6.3 Drug delivery
- 6.3.1 Parenteral
- 6.3.2 Oral
- 6.3.3 Other Drug deliveries
6.4 Other Applications

7 Global Bioresorbable Polymers Market, By Geography

7.1 Introduction
7.2 North America
- 7.2.1 US
- 7.2.2 Canada
- 7.2.3 Mexico
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 Italy
- 7.3.4 France
- 7.3.5 Spain
- 7.3.6 Rest of Europe
7.4 Asia Pacific
- 7.4.1 Japan
- 7.4.2 China
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 New Zealand
- 7.4.6 South Korea
- 7.4.7 Rest of Asia Pacific
7.5 South America
- 7.5.1 Argentina
- 7.5.2 Brazil
- 7.5.3 Chile
- 7.5.4 Rest of South America
7.6 Middle East & Africa
- 7.6.1 Saudi Arabia
- 7.6.2 UAE
- 7.6.3 Qatar
- 7.6.4 South Africa
- 7.6.5 Rest of Middle East & Africa

8 Key Developments

8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiling

9.1 Evonik Industries AG
9.2 Foster Corporation
9.3 Ashland Global Holdings Inc.
9.4 REVA Medical, LLC
9.5 Bezwada Biomedical, LLC
9.6 BMG Incorporated
9.7 Foryou Medical Devices Co., Ltd
9.8 Musashino Chemical Laboratory, Ltd.
9.9 Henan Xinghan Biotechnology Co. Ltd.
9.10 KLS Martin Group
9.11 DSM Biomedical
9.12 Corbion N.V.
9.13 Zeus Industrial Products
9.14 Abbott
9.15 3D Biotek LLC
9.16 Sunstar Suisse S.A.
9.17 Futerro